Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin
Science Advances · 2025
DOI: 10.1126/sciadv.adu9360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Laure Migayron und 19 weiteren Autor:innen. Beteiligte Einrichtung: CNRS, ImmunoConcEpT, UMR 5164, Univ. Bordeaux, F-33000 Bordeaux, France. Hauptthemen laut MEDLINE: Vitiligo, CD8-Positive T-Lymphocytes, Skin, Immunologic Memory. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Sanofi, Les Laboratories Pierre Fabre, Fondation d'Entreprise SILAB - Jean PAUFIQUE.
Abstract (Originalsprache)
Emerging evidence demonstrates that self-reactive CD8 + T resident memory cells (T RM cells) may already populate the never-lesional (NL) skin of patients with chronic inflammatory conditions, including vitiligo. However, their functional activity and regulation remain unknown. By combining cellular and transcriptomic approaches, we show that common CD8 + T cell clusters with a similar transcriptional profile infiltrate NL and peri-lesional (PL) skin of patients with vitiligo. Pathways related to immune activation were more active in T cells from PL skin, while those related to immune regulation were enriched in NL skin T cells, also evidenced by the stronger infiltration of regulatory T cells and the higher expression of programmed cell death protein 1 (PD-1) by CD8 + T cells in NL skin. Treatment of patients with baricitinib led to an increase in regulatory T cells and CD8 + T cells expressing PD-1 in repigmented skin. These findings suggest that functional T cells populate pigmented skin in vitiligo and highlight the importance of regulatory mechanisms to restrain their activation and prevent depigmentation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- CNRS, ImmunoConcEpT, UMR 5164, Univ. Bordeaux, F-33000 Bordeaux, France.
- R&D Department, SILAB, Brive-la-Gaillarde, France.
- Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, UMR 5164, CHU de Bordeaux, F-33000 Bordeaux, France.
- SciLicium, 10 rue de la Sauvaie, 35000 Rennes, France.
- Univ. Bordeaux, CNRS UAR 3427, INSERM US 005, TBMCore, FACSility, F-33000 Bordeaux, France.
- INSERM UMR-S 976 "Human Immunology, Pathophysiology and Immunotherapy," Research Institute of Saint-Louis, Université Paris Cité, Paris, France.
ORCID-Profile: Laure Migayron, Chloé Avril, Simon Léonard, Fanélie Jouenne, Emilian Mertinaj, Adèle Mauroux, Jean-Philippe Guégan, Samia Mourah, Katia Boniface
Förderung
- Sanofi
- Les Laboratories Pierre Fabre
- Fondation d'Entreprise SILAB - Jean PAUFIQUE
- Pfizer France
- LEO Pharma
- L'Oreal
- ISIS Pharma
- Societe de Recherche Dermatologique
Zitieren
APA
Migayron, L., Merhi, R., Avril, C., Léonard, S., Zouine, A., Jouenne, F., Gilardeau, S., Drullion, C., Thiolat, D., Mertinaj, E., Humeau, M., Mauroux, A., Guégan, J. P., Gauthereau, X., Mourah, S., Darde, T., Bordes, S., Closs-Gonthier, B., Seneschal, J., & Boniface, K. (2025). Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin. Science Advances. https://doi.org/10.1126/sciadv.adu9360
Vancouver
Migayron L, Merhi R, Avril C, Léonard S, Zouine A, Jouenne F, et al. Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin. Science Advances. 2025. doi:10.1126/sciadv.adu9360
BibTeX
@article{Migayron2025,
author = {Migayron, Laure and Merhi, Ribal and Avril, Chloé and Léonard, Simon and Zouine, Atika and Jouenne, Fanélie and Gilardeau, Sophie and Drullion, Claire and Thiolat, Denis and Mertinaj, Emilian and Humeau, Mélanie and Mauroux, Adèle and Guégan, Jean-Philippe and Gauthereau, Xavier and Mourah, Samia and Darde, Thomas and Bordes, Sylvie and Closs-Gonthier, Brigitte and Seneschal, Julien and Boniface, Katia},
title = {Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adu9360}
}
EUVIMED